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The circadian rhythm can be reset by a variety of substances. Prostaglandin J2 (PGJ2) is one such
substance and resets the circadian rhythm in ﬁbroblasts. In our current study, we examined the
phase-dependent phase shift following PGJ2 treatment using a real-time luciferase luminescence
monitoring system. In the phase response curves, we observed 12 h differences in the times of peaks
in comparison with the same analysis for forskolin. Quantiﬁcation of clock gene mRNAs following
PGJ2 administration additionally revealed a rapid decrease in the Per1, Rev-erbAa and Dbp levels.
Our current ﬁndings thus suggest that PGJ2 resets the peripheral circadian clock via a mechanism
that is distinct from that used by forskolin (FK).
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction a circadian rhythm and these cells thus provide a model systemEndogenous time keeping mechanisms generate the circadian
rhythm in mammals and are controlled via the master circadian
oscillator located in the hypothalamic suprachiasmatic nucleus
(SCN). The SCN itself comprises thousands of neurons, many of
which are equipped with an autonomous molecular mechanism
that generates ﬁring circadian rhythms [1]. Recent studies of the
circadian rhythm machinery have further revealed the nature of
these intracellular oscillators [2,3]. These reports have shown that
the basic circadian clock mechanism consists of a transcriptional/
translational feedback loop in which the expression of clock gene
mRNAs such as Per1, Per2, Cry1 and Cry2 is suppressed periodically
by their protein products [2,3].
Circadian rhythms are generated also in peripheral organs and
tissues [4]. In addition, cultured immortalized cell lines such as
Rat-1 [5] and NIH3T3 ﬁbroblasts [6] have been found to producechemical Societies. Published by E
thasone; FK, forskolin; DMSO,
cetate; SCN, suprachiasmatic
oshi).to dissect the molecular mechanisms underlying circadian oscilla-
tion. Dexamethasone (Dex), forskolin (FK), phorbol 12-myristate
13-acetate (PMA) and many other substances have now been dem-
onstrated to induce a circadian rhythm in ﬁbroblasts [7–9]. It has
been further demonstrated that the basic mechanism that gener-
ates the circadian rhythm is also used in the central clock [10]. Re-
cently, we have shown in our laboratory that C6 glioma cells also
generate a circadian rhythm following their exposure to Dex, FK,
and a high concentration of serum [11]. Moreover, we found in
the same study that the molecular machinery underlying the circa-
dian clock in C6 glioma cells is similar to that in the SCN as phase
differences among the clock genes were observed [11]. An advan-
tage of monitoring the circadian rhythm in C6 cells is that their
oscillation cells is sustained for a much longer period compared
with Rat-1 cells or NIH3T3 ﬁbroblasts [11].
Prostaglandin J2 (PGJ2) is one of the derivatives of PGD2 and has
been demonstrated to have a variety of effects such as anti-tumor-
igenesis and antiviral activity via the inhibition of viral protein
synthesis [12–15]. Recently, Nakahata et al. have reported that
PGJ2 generates a circadian rhythm for luciferase activity [16]. In
our present study, we have investigated the time-dependentlsevier B.V. All rights reserved.
414 S. Koinuma et al. / FEBS Letters 583 (2009) 413–418properties of circadian resetting and proﬁled the transcription of
clock genes in C6 glioma cells treated with PGJ2.
2. Materials and methods
2.1. Cell culture and real-time monitoring of circadian
bioluminescence
C6 glioma cells and C6-Per2::dluc cells were cultured in Dul-
becco’s modiﬁed Eagle’s medium (DMEM; Sigma, St. Louis, MO)
supplemented with 10% fetal bovine serum (FBS; ICN, Cleveland,
OH) at 37 C in a 5% CO2 atmosphere. Bioluminescence was mea-
sured using photomultiplier tube (PMT), detector assemblies (Kro-
nos, ATTO, Tokyo, Japan) or a real-time monitoring machine that
was previously fabricated in-house [17]. Cells were plated in
35 mm dishes and grew to 80–90% conﬂuence after two days of
culture. The medium was replaced with phenol-red free DMEM
containing luciferine (100 lM, Nacalai Tesque, Kyoto, Japan), Dex
(100 nM), and HEPES (15 mM) prior to setting the dishes on the
PMT detector assemblies. Treatments with PGJ2 (Nacalai Tesque,
Biomol, Plymouth Meeting, PA) or FK (Wako, Osaka, Japan) were
carried out at the indicated time points.
2.2. Construction of mPer2::dLuc-Neo
The construction of mPer2::dLuc has been described previously
[11,18]. This construct was digested with NotI and SalI and sub-
cloned into the corresponding sites in the EGFP-N1 vector (Clon-
tech, Mountain View, CA).
2.3. Stable transformants of the C6-Per2 dLuc cell line
C6 cells were grown in DMEM supplemented with 10% FBS and
plated at a density of 1.0  106 cells per dish in 35 mm dishes at0
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Fig. 1. Luciferase reporter activity before and after the administration of PGJ2 or FK. (A) A
(B) Vehicle (DMSO) was added 48 h after Dex administration as a control. (C) PGJ2 appl
indicates the time after Dex application and the Y-axis indicates luc activity (count). Th24 h prior to transfection. The cells were then transfected with
1 lg mPer2::dLuc-Neo using LipofectAMINE 2000 reagent (Invitro-
gen, Carlsbad, CA) according to the manufacturer’s instructions.
After 24 h, the transfected cells were re-plated in 90-mm dishes.
Forty-eight hours later, the medium was replaced with 10 ml
DMEM supplemented with 10% FBS and 400 lg/ml G418 (Gibco,
Carlsbad, CA). The medium was subsequently changed every two
days. At conﬂuence, the cells were again re-plated in 90-mm
dishes. At one month after transfection, the colonies were selected
under an inverted light microscope and transferred to individual
wells on a 24-well plate. After these individual clones reached con-
ﬂuence, the cell populations were expanded in 90-mm dishes.
2.4. Quantitative RT-PCR
At the indicated time points after treatment with PGJ2 or FK,
cultured cells were harvested in 400 ll Sepasol RNA1 Super (Nac-
alai Tesque) and total RNA was extracted. One microgram of each
total RNA preparation was then reverse-transcribed using ReverTra
Ace (Toyobo, Osaka, Japan) and 2.5 lM of random nanomers. Taq-
Man real-time PCR (qPCR) was next carried out using an ABI PRISM
7900HT (Applied Biosystems, Foster City, CA), in a total volume of
15 ll using Premix Ex Taq (Perfect Real Time, Takara, Otsu, Japan),
according to the supplier’s instructions. mRNA quantiﬁcation was
performed using primers and ﬂuorescent probes as follows: rPer1:
forward primer, GCTCTCAGAGTTTGTGCGATGA; reverse primer,
AAAAGACACAAGCAGTCACACAAATA; probe, TTGTTCATGCGCAAA-
CCAAACGTACC; rPer2: forward primer, GCTCTCAGAGTTTGTGC-
GATGA; reverse primer, AAAAGACACAAGCAGTCACACAAATA;
probe, TTGTTCATGCGCAAACCAAACGTACC; rCry1: forward primer,
TTCGTCAGGAGGGCTGGAT; reverse primer, GCCGCGGGTCAGGAA;
probe, CACC ATCTAGCCCGACATGCAGTTGC; rBmal1: forward pri-
mer, CTGAGCTGCCTCGTTGCA; reverse primer, CCCGTATTTCCCCG-
TTCACT; probe, TCGGGCGACTGCACTCACACATG; rRev-ErbAa0 24 48 72 96
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pplication of 20 lM PGJ2 to mPer2::dluc/C6 glioma cells at 48 h after Dex treatment.
ication at 36 h after Dex. (D) A DMSO control was added 36 h after Dex. The X-axis
e arrowheads indicate luciferase activity peaks.
S. Koinuma et al. / FEBS Letters 583 (2009) 413–418 415(rNr1d1): forward primer, TGAAAAACGAGAACTGCTCCATT; reverse
primer, CCAACGGAGAGACACTTCTTGAA; probe, TATCAATCGCAACC
GCTGCCAGC; and rDbp: forward primer, TGCCCTGTCAAGCATTCCA;
reverse primer, AGGCTTCAATTCCTCCTCTGAGA; probe, CCATGA-
GACTTTTGACCCTCGGAGGC; rRora: forward primer, CCCGAACCC-
ATATGTGACTACA; reverse primer, AAGTCTCTCCGTTGGTGAAGGA;
probe, ACCAGCATCTGGCTTCTTCCCCTACTG. For the normalization
of template concentrations, a primer set and probe for 18S ribo-
somal RNA (Applied Biosystems) were used. To generate a standard
curve, PCR products that had been ampliﬁed using the primers
listed above were serially diluted from 104 to 1010.
2.5. Measurement of the circadian period of C6-Per2 dLuc cells
The circadian period (s was calculated from the averaged circa-
dian period of luciferase luminescence rhythms measured by the
interval between the third and fourth peaks after the administra-
tion of PGJ2, forskolin or vehicle dimethyl sulfoxide (DMSO). CT 0
was deﬁned as the time of Dex administration. One hour phase
shifts were calculated by dividing each circadian period by 24.
2.6. Statistical analysis
Values are expressed as the mean ± S.E.M., and one-way analy-
sis of variance (ANOVA) with the Fisher’s PLSD post hoc test was
used to measure statistical differences. P values of <0.05 were con-
sidered to be signiﬁcant.0
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Fig. 2. Time-dependency of the phase shifts in luciferase activity and Per2 expression in
CT24 during the second cycle of the circadian rhythm after Dex administration were plott
after Dex stimulation, the Y-axis indicates the relative abundance of Per2 mRNA. (D) C
expression (above) with the PRC (below). Values are the mean ± S.E.M. (n = 3).3. Results
The luciferase activity levels in C6 glioma cells show a stable
circadian oscillation when the cells are treated with Dex and this
greatly facilitates the analysis of oscillation parameters such as
phase and period. Using this reporter system, we evaluated
whether PGJ2 affected the circadian oscillation phase and period
by adding it to the medium at 36 h and 48 h after Dex administra-
tion to a ﬁnal concentration of 20 lM (Fig. 1). After Dex adminis-
tration, the luciferase activity levels peaked at around 5 h with a
second peak occurring at around 28 h after this exposure. At 36 h
after Dex treatment, during which the luciferase activity was on
a decreasing phase, PGJ2 administration had little effect upon the
phase of the circadian oscillation. In contrast, PGJ2 administration
at 48 h after Dex administration delayed the next peak by 10 h.
In addition, we quantitated the amount of Per2 mRNA in a sequen-
tial manner from 72 to 96 h after Dex administration under condi-
tions where PGJ2, FK, and vehicle were administered at 48 h after
Dex was added to the cells. As a result, PGJ2 administered at 48 h
after Dex administration produced an advanced appearance of
the peak of approximately 8 h, but neither FK nor vehicle gener-
ated such a shift. These results are consistent with the ﬁndings
we obtained using luciferase reporter activity rhythms (Supple-
mentary Fig. 1).
To further analyze the proﬁles of the phase shift caused by PGJ2
in C6 glioma cells, we examined the circadian rhythm in these cells
via luciferase reporter activity following the administration of PGJ20
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C6 cells. The phase shifts induced by PGJ2 (A) or FK (B) administration from CT0 to
ed (n = 3). (C) Per2 expression after Dex administration. The X-axis indicates the time
omparison of the data shown in (A), (B) and (C) to compare time-dependent Per2
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Fig. 3. Clock gene expression proﬁles in C6 cells after the administration of 20 lM PGJ2 (solid lines) and vehicle (dotted lines). The relative amounts of the Per1, Per2, Cry1,
Rora, Bmal1, Rev-erbAa and Dbp transcripts after PGJ2 administration are indicated. The values measured at 48 h after Dex administration were adjusted to 100 and the results
are the mean ± S.E.M. of three independent experiments. **P < 0.01, *P < 0.05 (ANOVA).
416 S. Koinuma et al. / FEBS Letters 583 (2009) 413–418and FK at various time points from 25 to 48 h after Dex treatment
(Fig. 2). PGJ2 shows a signiﬁcantly shortened circadian period com-
pared to vehicle but not compared to FK (Supplementary Fig. 2).
The addition of PGJ2 at CT 21.5 (circadian time is determined by
the circadian period; CT 0 refers to the time of Dex administration)induced the longest observed delay (Fig. 2A and D). The addition of
PGJ2 at around CT 13 did not show a signiﬁcant phase shift. We
next compared these phase shift proﬁles with those obtained using
FK, a compound which has been reported to induce phase shifts in
immortalized cell lines such as Rat-1 [7]. When FK was
S. Koinuma et al. / FEBS Letters 583 (2009) 413–418 417administered to the C6 glioma cells at around CT 14, the cells
showed the greatest detected phase shift (8.9 h) (Fig. 2B and D).
In contrast, FK treatment at around CT 2 in the C6 cells produced
a phase shift of only 0.6 h.
Given that the circadian rhythm associated with the luciferase
reporter activity in our C6 cell system was under the control of
the endogenous circadian transcriptional/translational feedback
mechanism in these cells, we conclude from our data that the ob-
served shifts must be linked to those in the core feedback loop [19].
To therefore examine which genes were initially responsive to the
administration of PGJ2, we quantitated the transcript levels of
canonical clock genes such as Per1, Per2, Cry1, Rora, Bmal1, Rev-er-
bAa and Dbp over a 20 h period after PGJ2 administration at 48 h
after Dex treatment (Fig. 3). Among these genes, the earliest
detectable occurrence after PGJ2 treatment was a rapid decrease
of Rev-erbAa and Dbp. Rev-erbAa showed a trough at around 4 h,
which was about 4 h earlier than the control. Dbp produced an ini-
tial trough at approximately 8 h after PGJ2 treatment and then a
peak at 16 h, which was at least 4 h earlier than the peak of Dbp
expression in the control. Per1 showed a rapid increase by 1 h
and a decrease by 2 h after PGJ2 treatment. The lower levels of
expression of this gene compared with the control continued up
until 20 h after PGJ2 administration. On the other hand, Per2 and
Bmal1 showed signiﬁcant decreases at 16 h and 20 h following
PGJ2 exposure, respectively.4. Discussion
The stark differences in the phase response curves (PRCs) of C6
cells following PGJ2 and FK administration are likely to stem from
differences in the transcriptional regulation of clock genes. Many
substances have been reported to produce circadian rhythms in
ﬁbroblasts [7], astrocytes [20] and glioma cells [11]. Much evi-
dence now also suggests that Per1 and Per2 induction by exoge-
nous stimulation results in the shift of the core circadian
feedback loop [21–24]. This hypothesis was ﬁrst applied to the
central clock [21,22,25] but has also now been proposed for the
peripheral clocks [26]. In contrast, PGJ2 exposure decreased the
levels of Per1 which contrasts with other phase shifts induced by
FK, Dex, and serum shock, all of which are followed by a rapid in-
crease in Per1 transcription. Some studies have demonstrated that
a dark pulse phase shift (a phase shift caused by a short dark period
during the day) is associated with Per1 downregulation [23,27–29].
Hence, the Per1 downregulation resulting from PGJ2 administration
may generate such a shift.
We quantiﬁed the levels of clock gene transcripts in C6 cells fol-
lowing Dex administration [11]. When we compared the circadian
alteration of the Per2 and Bmal1mRNAs using a PRC, we found that
the largest shifts resulting from PGJ2 exposure corresponded to a
Per2 peak (Fig. 2C) and a Bmal1 trough. The corollary of this was
that the smallest shifts corresponded to a Per2 trough and a Bmal1
peak. In the SCN, Per2 expression is upregulated and Bmal1 is
downregulated during the daytime with the opposite being the
case at night. Hence, it is highly probable that FK shifts the circa-
dian rhythm via a light pulse type of phase shift but that PGJ2 does
so using a dark pulse.
In our present study, the Per1, Rev-erbAa and Dbp clock genes
exhibited a rapid reduction in their transcript levels and the Rev-
erbAa and DbpmRNAs showed circadian oscillation shifts. It is thus
possible that differences in the responses to exogenous stimulants
alter the time dependency of the associated phase shift. In addi-
tion, each of the genes suppressed by PGJ2 has a functional E-box
in their regulatory regions [19], suggesting the possibility that E-
box activity is suppressed by as yet uncharacterized but PGJ2-
linked transcriptional regulation mechanisms.In conclusion, we show herein that PGJ2 shifts the transcrip-
tional circadian rhythm in C6 glioma cells with a distinct time
dependency. The PRC and the levels of clock gene transcripts asso-
ciated with this suggest that PGJ2 generates a phase shift by a
mechanism that is similar to a dark pulse.
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